Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

2.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
2.2K
Assessing Body Temperature - Axilla01:14

Assessing Body Temperature - Axilla

1.9K
Procedural Guide for Assessing Axillary Body Temperature using a Digital Thermometer:
Step 1: Perform hand hygiene and put on clean gloves to maintain infection control and prevent cross-contamination.
Step 2: Prepare the patient by explaining the procedure to ensure understanding and cooperation. Ensure privacy, expose the axilla, and inform the patient that minimal movement is crucial for an accurate reading.
Step 3: Adjust the patient’s clothing to expose only the axilla. It minimizes...
1.9K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

1.3K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
1.3K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

767
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
767

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Core Outcome Domain Set for Facial Aging.

JAMA dermatology·2026
Same author

Calcium Hydroxylapatite-Carboxymethylcellulose as a Treatment for Forearm Dermatoporosis: A Prospective, Delayed-Start, Contralateral Case Series.

Journal of cosmetic dermatology·2026
Same author

Reaffirming the Anatomical and Biomechanical Safety Foundations of the V-Lift Technique.

Aesthetic plastic surgery·2025
Same author

Long-Term Consecutive OnabotulinumtoxinA Injections for Facial Aesthetic Treatment: A Real-World Study.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2025
Same author

A Study of Glabellar Contraction Patterns in African Descendants.

Journal of drugs in dermatology : JDD·2025
Same author

Treating the Latin American Aesthetic Patient: A Review.

Clinical, cosmetic and investigational dermatology·2024

Related Experiment Video

Updated: Apr 25, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

24.4K

Botulinum toxin for axillary hyperhidrosis.

Ada Regina Trindade de Almeida1, Suelen Montagner2

  • 1Department of Dermatology, Hospital do Servidor Público Municipal de São Paulo (SP), Rua Turiaçu, 390, cjs 113-114, Perdizes, São Paulo, São Paulo 05005-000, Brazil.

Dermatologic Clinics
|August 26, 2014
PubMed
Summary
This summary is machine-generated.

Botulinum toxin effectively treats axillary hyperhidrosis by temporarily inhibiting sweating. Proper identification of the affected area and experienced injection techniques are crucial for optimal results in managing excessive sweating.

Keywords:
Axillary hyperhidrosisBotoxBotulinum toxinExcessive underarm sweatingNeuromodulators

More Related Videos

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
04:25

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

Published on: November 8, 2024

2.2K
Quantitative Autonomic Testing
11:40

Quantitative Autonomic Testing

Published on: July 19, 2011

59.2K

Related Experiment Videos

Last Updated: Apr 25, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

24.4K
Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
04:25

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

Published on: November 8, 2024

2.2K
Quantitative Autonomic Testing
11:40

Quantitative Autonomic Testing

Published on: July 19, 2011

59.2K

Area of Science:

  • Dermatology
  • Neurology

Background:

  • Axillary hyperhidrosis, or excessive underarm sweating, presents a significant challenge for many individuals.
  • The precise pathophysiology of hyperhidrosis remains incompletely understood, though neuromodulators are recognized for their temporary inhibitory effects on localized sweating.

Purpose of the Study:

  • To highlight botulinum toxin as a safe and effective treatment for axillary hyperhidrosis.
  • To emphasize the importance of accurate identification of the hyperhidrotic area before treatment.
  • To discuss the role of medical expertise in optimizing drug utilization and patient comfort during the procedure.

Main Methods:

  • Review of the established use of botulinum toxin for axillary hyperhidrosis.
  • Discussion of pre-procedural assessment for precise localization of sweating.
  • Consideration of variable injection techniques and dilution methods based on clinical experience.

Main Results:

  • Botulinum toxin demonstrates efficacy in managing axillary hyperhidrosis.
  • Accurate mapping of the affected region is essential for treatment success.
  • Variations in technique, guided by experience, can enhance efficacy and patient comfort.

Conclusions:

  • Botulinum toxin is a viable therapeutic option for axillary hyperhidrosis.
  • Careful pre-treatment assessment and skilled application are key to successful outcomes.
  • Medical experience influences the optimization of botulinum toxin therapy for hyperhidrosis.